News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
129 Results
Type
Article (11)
Press Release (118)
Section
Business (42)
Deals (6)
Drug Development (6)
FDA (4)
Job Trends (1)
News (57)
Policy (9)
Tag
Alliances (16)
Approvals (5)
Best Places to Work (1)
Breast cancer (1)
Cancer (2)
CAR-T (1)
Cell therapy (1)
Clinical research (6)
Collaboration (1)
COVID-19 (1)
C-suite (1)
Data (1)
Diagnostics (41)
Earnings (13)
Events (21)
Executive appointments (1)
FDA (5)
Government (2)
Healthcare (1)
Infectious disease (1)
IPO (5)
Legal (3)
Lymphoma (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (1)
People (16)
Phase 1 (5)
Phase 2 (2)
Phase 3 (3)
Pipeline (2)
Regulatory (9)
Startups (1)
Date
Last 30 days (1)
Last 365 days (9)
2026 (1)
2025 (8)
2024 (7)
2023 (9)
2022 (15)
2021 (13)
2020 (13)
2019 (7)
2018 (13)
2017 (11)
2016 (2)
2015 (11)
2014 (4)
2013 (5)
2012 (3)
2011 (3)
2010 (3)
Location
Asia (5)
Australia (17)
Europe (57)
Illinois (5)
United States (5)
129 Results for "biocartis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures
January 13, 2026
·
2 min read
Press Releases
Press Release Biocartis NV: Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025
November 17, 2025
·
5 min read
Press Releases
Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
September 16, 2025
·
3 min read
Press Releases
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
August 19, 2025
·
2 min read
Press Releases
Press Release Biocartis NV: Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing
June 18, 2025
·
2 min read
Press Releases
Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test
June 2, 2025
·
3 min read
Press Releases
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay
April 2, 2025
·
4 min read
Press Releases
Press Release Biocartis NV: Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla™ in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting
March 18, 2025
·
8 min read
Press Releases
Press Release Biocartis NV: Biocartis appoints Randy Polonsky as Chief Financial Officer
November 6, 2024
·
1 min read
Press Releases
Press Release Biocartis NV: Biocartis announces new data on early CAR-T vector load assessment with Idylla™ presented at ASTCT: A Potential Breakthrough in LBCL Treatment Monitoring
February 14, 2025
·
3 min read
1 of 13
Next
